Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics [Phase 4]
A Phase 4 trial evaluating sequential use of formoterol and budesonide via Aerolizer in asthmatics has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-10Clinical Trial Update: Mechanisms of Response to Diesel Exhaust in Subjects With Asthma
A clinical trial investigating mechanisms of response to diesel exhaust in subjects with asthma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-30Clinical Trial Update: Pilot Study of Magnesium Infusions in Pediatric Asthma [Phase 2, Phase 3]
A Phase 2/Phase 3 pilot trial evaluating intravenous magnesium infusions for pediatric asthma has been withdrawn. No results are reported.
-
CLINICAL_TRIALS withdrawal · 2017-03-03Clinical Trial Update: The Long-term Prognosis of Moderate to Severe Bronchial Hyperresponsiveness (BHR) in Asthmatic Preschool Children
A withdrawn clinical trial examining the long-term prognosis of bronchial hyperresponsiveness in preschool children with intrinsic or allerg…
-
EMA withdrawal · 2017-01-31EMA Withdrawn: Budesonide/Formoterol Teva (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.
EMA confirms withdrawal of Budesonide/Formoterol Teva, a combination inhaled therapy, from the product market.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2017-01-30EMA Withdrawn: Budesonide/Formoterol Teva Pharma B.V. (Budesonide;formoterol) — Teva Pharma B.V.
The EMA withdrew the Budesonide/Formoterol Teva Pharma B.V. product, a combination therapy for asthma, from its marketing authorization.
-
EMA withdrawal · 2017-01-26EMA Withdrawn: Vylaer Spiromax (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.
The EMA has withdrawn Vylaer Spiromax (budesonide/formoterol) from the market in the EU.
-
CLINICAL_TRIALS withdrawal · 2017-01-16Clinical Trial Update: Asthma Clinical Research Network (ACRN) [Phase 3]
A Phase 3 trial under the Asthma Clinical Research Network has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-12Clinical Trial Update: Smoking Cessation Peds Asthma [NA]
The pediatric smoking cessation and asthma clinical trial (NCT02640521) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-04Clinical Trial Update: Pilot Study of RNS60 in Allergen-induced Bronchoconstriction [Phase 2]
The Phase 2 pilot trial of RNS60 for allergen-induced bronchoconstriction in asthma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-24Clinical Trial Update: A Study of RO5036505 in Patients With Moderate to Severe Asthma [Phase 2]
A Phase 2 study of the Roche compound RO5036505 in moderate-to-severe asthma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-08-10Clinical Trial Update: Use of Vitamin D3 for the Treatment of Steroid Resistant Asthmatic Patients [Phase 2]
A Phase 2 clinical trial evaluating vitamin D3 for steroid-resistant asthma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-29Clinical Trial Update: The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa
A clinical trial investigating the clinical and laboratory phenotypes of severe asthma patients in Clalit Health Services Haifa has been wit…
-
CLINICAL_TRIALS withdrawal · 2016-06-16Clinical Trial Update: Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo [NA]
A clinical trial evaluating Advair Diskus (fluticasone propionate/salmeterol) versus placebo for adolescents and adults with asthma and seas…
-
CLINICAL_TRIALS withdrawal · 2016-05-26Clinical Trial Update: Tiotropium for Smoking Asthmatics Study [Phase 4]
A Phase 4 trial evaluating tiotropium in smokers with asthma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-21Clinical Trial Update: Web System for Engaging Families & Doctors in Continuous Asthma Quality Improvement [NA]
A clinical trial evaluating a web-based system to engage families and doctors in ongoing asthma quality improvement has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-22Clinical Trial Update: Asthma Exacerbation Study [NA]
A clinical trial on asthma exacerbation was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-04Clinical Trial Update: Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma [Phase 1, Phase 2]
This clinical trial update reports that the Phase 1/2 study of QAX576 for adults with moderate persistent allergic asthma has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2016-02-03Clinical Trial Update: The Comparison of Electronic Auscultation Coupled With CALSA and FRI; Repeatability of FRI Biomarkers [NA]
The clinical trial evaluating electronic auscultation with CALSA and FRI for asthma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-29Clinical Trial Update: Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure [Phase 3]
A Phase 3 trial evaluating the Hattler Respiratory Assist Catheter for severe respiratory failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-14Clinical Trial Update: Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1) [Phase 2]
A Phase 2 trial of SCH 527123 in subjects with severe asthma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-16Clinical Trial Update: A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003) [Phase 1]
A Phase 1 single-dose trial of MK-8351 in an asthma lung allergen challenge was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-25Clinical Trial Update: CryoSpray Ablation(tm)Thoracic Patient Registry
A thoracic patient registry evaluating CryoSpray Ablation has been withdrawn from the trial registry. The study covered conditions including…
-
CLINICAL_TRIALS withdrawal · 2015-06-01Clinical Trial Update: Bronchoscopy Study for Severe Asthma
A bronchoscopy study for severe asthma sponsored by the University of Pennsylvania has been withdrawn. The trial identifier is NCT01745809.
-
CLINICAL_TRIALS withdrawal · 2015-04-17Clinical Trial Update: No Resistance After Long Term Treatment SERETIDE [Phase 4]
A Phase 4 trial of SERETIDE for asthma has been withdrawn. The update notes no resistance after long-term treatment.